VivoSim Labs, INC. (VIVS)

Latest Insider Confidence Score

2026Q1

50.0
Bullish

Company insider confidence (by quarter)

2012Q1 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Forgacs Gabor — 6,053,991 Mar 13, 2012
Kimberlin Kevin — 1,187,399 Feb 14, 2013
David Eric CSO & EVP Pre-Clinical Dev 876,609 Nov 16, 2017
Michaels Barry D CFO 372,454 May 11, 2016
Presnell Sharon Collins Chief Scientific Officer 280,993 Nov 20, 2018

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jan 27, 2026 Jan 29, 2026 Cohen Douglas Jay Director Neutral 90.0 +15,000 254.32% ✗ -
Jan 27, 2026 Jan 29, 2026 Murphy Keith Chair Neutral 90.0 +15,000 135.71% ✗ -
Jan 27, 2026 Jan 29, 2026 Milhous Alison Tjosvold Director Neutral 90.0 +15,000 306.18% ✗ -
Jan 27, 2026 Jan 29, 2026 Gobel David Director Neutral 90.0 +15,000 100.00% ✗ -
Jan 27, 2026 Jan 29, 2026 STERN ADAM K Director Neutral 90.0 +15,000 306.18% ✗ -
Nov 25, 2025 Nov 26, 2025 Sethi Amar Akhtar Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Nov 26, 2025 Sethi Amar Akhtar Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Nov 17, 2025 Nov 19, 2025 Gobel David Director Buy 52.5 - 0.00% ✗ $7.3K
Aug 11, 2025 Aug 21, 2025 Lialin Tony Serge Chief Commercial Officer Neutral 52.5 - 0.00% ✗ -
Aug 21, 2025 Lialin Tony Serge Chief Commercial Officer Neutral 52.5 - 0.00% ✗ -
Jan 8, 2025 Staskey Norm Officer Neutral 52.5 - 0.00% ✗ -
Aug 7, 2024 Aug 9, 2024 Gobel David Director Neutral 90.0 +19,607 100.00% ✗ -
Aug 7, 2024 Aug 9, 2024 Cohen Douglas Jay Director Neutral 90.0 +19,607 38.28% ✗ -
Aug 7, 2024 Aug 9, 2024 Milhous Alison Tjosvold Director Neutral 90.0 +19,607 50.00% ✗ -
Aug 7, 2024 Aug 9, 2024 STERN ADAM K Director Neutral 90.0 +19,607 50.00% ✗ -
Aug 7, 2024 Aug 9, 2024 Joshi Vaidehi Director Neutral 90.0 +19,607 50.00% ✗ -
Aug 7, 2024 Aug 7, 2024 Murphy Keith Chair Neutral 90.0 +19,607 17.35% ✗ -
Nov 17, 2023 Nov 17, 2023 STERN ADAM K Director Neutral 90.0 +19,607 100.00% ✗ -
Nov 17, 2023 Nov 17, 2023 Milhous Alison Tjosvold Director Neutral 90.0 +19,607 100.00% ✗ -
Nov 17, 2023 Nov 17, 2023 Cohen Douglas Jay Director Neutral 90.0 +19,607 62.03% ✗ -
Nov 17, 2023 Nov 17, 2023 Murphy Keith Chair Neutral 90.0 +19,607 20.99% ✗ -
Nov 15, 2023 Nov 17, 2023 Gobel David Director Sell 51.3 - 0.00% ✗ $31.7K
Nov 17, 2023 Nov 17, 2023 Joshi Vaidehi Director Neutral 90.0 +19,607 100.00% ✗ -
Nov 10, 2022 Nov 14, 2022 Gobel David Director Neutral 90.0 +19,607 100.00% ✗ -
Nov 10, 2022 Nov 14, 2022 STERN ADAM K Director Neutral 90.0 +19,607 100.00% ✗ -
Nov 10, 2022 Nov 14, 2022 Murphy Keith Chair Neutral 90.0 +19,607 26.56% ✗ -
Nov 10, 2022 Nov 14, 2022 Milhous Alison Tjosvold Director Neutral 90.0 +19,607 100.00% ✗ -
Nov 10, 2022 Nov 14, 2022 Cohen Douglas Jay Director Neutral 90.0 +19,607 163.39% ✗ -
Nov 10, 2022 Nov 14, 2022 Joshi Vaidehi Director Neutral 90.0 +19,607 100.00% ✗ -
Aug 31, 2022 Oct 20, 2022 JURGENSEN THOMAS E General Counsel & Secretary Neutral 52.5 - 0.00% ✗ -
Aug 31, 2022 Oct 20, 2022 Miner Jeffrey N. Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Aug 31, 2022 Oct 20, 2022 Murphy Keith Chair Neutral 52.5 - 0.00% ✗ -
Nov 19, 2021 Jul 8, 2022 Gobel David Director Sell 27.5 -145 -100.00% ✗ $766.3
Mar 8, 2022 Mar 10, 2022 Joshi Vaidehi Director Neutral 52.5 - 0.00% ✗ -
Mar 10, 2022 Joshi Vaidehi Director Neutral 52.5 - 0.00% ✗ -
Nov 1, 2021 Hess Thomas CFO Neutral 52.5 - 0.00% ✗ -
Oct 7, 2021 Oct 12, 2021 Gobel David Director Neutral 52.5 - 0.00% ✗ -
Oct 7, 2021 Oct 12, 2021 JURGENSEN THOMAS E General Counsel & Secretary Neutral 52.5 - 0.00% ✗ -
Oct 7, 2021 Oct 12, 2021 Miner Jeffrey N. Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Oct 7, 2021 Oct 12, 2021 Milhous Alison Tjosvold Director Neutral 52.5 - 0.00% ✗ -
Oct 7, 2021 Oct 12, 2021 Murphy Keith Chair Neutral 52.5 - 0.00% ✗ -
Oct 7, 2021 Oct 12, 2021 Cohen Douglas Jay Director Neutral 52.5 - 0.00% ✗ -
Oct 7, 2021 Oct 12, 2021 STERN ADAM K Director Neutral 52.5 - 0.00% ✗ -
Aug 17, 2021 Aug 19, 2021 Cohen Douglas Jay Director Buy 95.0 +10,750 860.00% ✗ $72.3K
Mar 8, 2021 Mar 10, 2021 Miner Jeffrey N. Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Mar 8, 2021 Mar 10, 2021 JURGENSEN THOMAS E General Counsel & Secretary Neutral 52.5 - 0.00% ✗ -
Mar 8, 2021 Mar 10, 2021 Murphy Keith Chair Neutral 90.0 +20,000 43.18% ✗ -
Sep 15, 2020 Dec 11, 2020 Murphy Keith Chair Neutral 52.5 - 0.00% ✗ -
Sep 15, 2020 Sep 17, 2020 STERN ADAM K Director Neutral 52.5 - 0.00% ✗ -
Sep 15, 2020 Sep 17, 2020 Murphy Keith Chair Neutral 52.5 - 0.00% ✗ -
Sep 15, 2020 Sep 17, 2020 Miner Jeffrey N. Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Sep 15, 2020 Sep 17, 2020 Milhous Alison Tjosvold Director Neutral 52.5 - 0.00% ✗ -
Sep 15, 2020 Sep 17, 2020 JURGENSEN THOMAS E General Counsel & Secretary Neutral 52.5 - 0.00% ✗ -
Sep 15, 2020 Sep 17, 2020 Heberlig Chris CFO Neutral 52.5 - 0.00% ✗ -
Sep 15, 2020 Sep 17, 2020 Gobel David Director Neutral 52.5 - 0.00% ✗ -
Sep 15, 2020 Sep 17, 2020 Cohen Douglas Jay Director Neutral 52.5 - 0.00% ✗ -
Sep 17, 2020 Miner Jeffrey N. Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Sep 17, 2020 Milhous Alison Tjosvold Director Neutral 52.5 - 0.00% ✗ -
Sep 17, 2020 JURGENSEN THOMAS E General Counsel & Secretary Neutral 52.5 - 0.00% ✗ -
Sep 17, 2020 Heberlig Chris CFO Neutral 52.5 - 0.00% ✗ -
Sep 17, 2020 Gobel David Director Neutral 52.5 - 0.00% ✗ -
Sep 17, 2020 Cohen Douglas Jay Director Neutral 52.5 - 0.00% ✗ -
Aug 18, 2020 Aug 18, 2020 KUSSMAN CRAIG CFO Sell 47.5 -15,700 -6.61% ✗ $8.9K
Aug 18, 2020 Aug 18, 2020 CROUCH TAYLOR CEO Sell 47.5 -5,510 -4.22% ✗ $3.1K
Aug 18, 2020 Aug 18, 2020 Bush Jennifer General Counsel & Secretary Sell 47.5 -10,900 -5.35% ✗ $6.2K
Jul 22, 2020 Murphy Keith Director Neutral 52.5 - 0.00% ✗ -
Jul 22, 2020 STERN ADAM K Director Neutral 52.5 - 0.00% ✗ -
May 18, 2020 May 20, 2020 KUSSMAN CRAIG CFO Sell 47.5 -18,030 -7.06% ✗ $9.3K
May 18, 2020 May 20, 2020 CROUCH TAYLOR CEO Sell 47.5 -6,340 -4.63% ✗ $3.3K
May 18, 2020 May 20, 2020 Bush Jennifer General Counsel & Secretary Sell 47.5 -14,630 -6.70% ✗ $7.5K
Feb 19, 2020 Feb 20, 2020 KUSSMAN CRAIG CFO Sell 47.5 -17,100 -6.27% ✗ $5.5K
Feb 19, 2020 Feb 20, 2020 CROUCH TAYLOR CEO Sell 47.5 -6,045 -4.23% ✗ $1.9K
Feb 19, 2020 Feb 20, 2020 Bush Jennifer General Counsel & Secretary Sell 47.5 -13,850 -5.97% ✗ $4.4K
Nov 18, 2019 Nov 19, 2019 KUSSMAN CRAIG CFO Sell 47.5 -14,410 -5.02% ✗ $6.5K
Nov 18, 2019 Nov 19, 2019 CROUCH TAYLOR CEO Sell 47.5 -5,075 -3.43% ✗ $2.3K
Nov 18, 2019 Nov 19, 2019 Bush Jennifer General Counsel & Secretary Sell 47.5 -11,695 -4.80% ✗ $5.3K
Sep 5, 2019 Sep 9, 2019 Shapiro David Director Neutral 52.5 - 0.00% ✗ -
Sep 5, 2019 Sep 9, 2019 Maroun Richard E Director Neutral 52.5 - 0.00% ✗ -
Sep 5, 2019 Sep 9, 2019 Malloy Kirk Director Neutral 52.5 - 0.00% ✗ -
Sep 5, 2019 Sep 9, 2019 KESSEL MARK Director Neutral 52.5 - 0.00% ✗ -
Sep 5, 2019 Sep 9, 2019 BEAVER CAROLYN Director Neutral 52.5 - 0.00% ✗ -
Aug 16, 2019 Aug 19, 2019 KUSSMAN CRAIG CFO Sell 47.5 -14,750 -4.89% ✗ $4.2K
Aug 16, 2019 Aug 19, 2019 Hughes Steven George Chief Medical Officer Sell 27.5 -22,230 -13.83% ✗ $6.4K
Aug 16, 2019 Aug 19, 2019 Gallant Paul General Manager Sell 47.5 -9,500 -4.73% ✗ $2.7K
Aug 16, 2019 Aug 19, 2019 CROUCH TAYLOR CEO Sell 47.5 -5,300 -3.45% ✗ $1.5K
Aug 16, 2019 Aug 19, 2019 Bush Jennifer General Counsel & Secretary Sell 47.5 -11,960 -4.68% ✗ $3.4K
Jul 8, 2019 Jul 10, 2019 BEAVER CAROLYN Director Neutral 52.5 - 0.00% ✗ -
May 16, 2019 May 20, 2019 KUSSMAN CRAIG CFO Sell 46.3 -15,155 -4.78% ✗ $14.7K
May 16, 2019 May 20, 2019 Gallant Paul General Manager Sell 47.5 -9,274 -4.41% ✗ $9K
May 16, 2019 May 20, 2019 CROUCH TAYLOR CEO Sell 47.5 -5,465 -3.44% ✗ $5.3K
May 16, 2019 May 20, 2019 Bush Jennifer General Counsel & Secretary Sell 46.3 -12,275 -4.58% ✗ $11.9K
Feb 19, 2019 Feb 21, 2019 KUSSMAN CRAIG CFO Sell 46.3 -16,215 -4.87% ✗ $17.3K
Feb 19, 2019 Feb 21, 2019 Gallant Paul General Manager Sell 46.3 -10,410 -4.72% ✗ $11.1K
Feb 19, 2019 Feb 21, 2019 CROUCH TAYLOR CEO Sell 47.5 -5,665 -3.44% ✗ $6K
Feb 19, 2019 Feb 21, 2019 Bush Jennifer General Counsel & Secretary Sell 46.3 -13,520 -4.80% ✗ $14.4K
Feb 21, 2019 BEAVER CAROLYN Director Neutral 52.5 - 0.00% ✗ -
Dec 4, 2018 Dec 6, 2018 Shapiro David Director Neutral 52.5 - 0.00% ✗ -
Dec 6, 2018 Shapiro David Director Neutral 52.5 - 0.00% ✗ -
Nov 16, 2018 Nov 20, 2018 Presnell Sharon Collins Chief Scientific Officer Sell 46.3 -11,200 -3.83% ✗ $12K
Nov 16, 2018 Nov 20, 2018 KUSSMAN CRAIG CFO Sell 46.3 -14,720 -4.23% ✗ $15.7K